Crescent Biopharma Insider Sales: Executives Sell Shares to Cover Taxes Amid Routine Vesting Plans
Insider selling at Crescent Biopharma signals routine tax‑covering moves, not a loss of confidence—investors should track future filings for any significant shifts.
3 minutes to read
